LIO-1: Initial phase 2 experience of lucitanib + nivolumab in patients with metastatic or recurrent cervical cancer (NCT04042116; ENGOT-GYN3/AGO/LIO) Meeting Abstract
| Authors: | Oaknin, A.; Backes, F.; Van Nieuwenhuysen, E.; Eskander, R.; González-Martín, A.; Makker, V.; Marth, C.; Patel, M.; Penson, R.; Redondo, A.; Pérez, M. J. R.; Hamilton, E.; Concin, N.; McNees, A.; Wride, K.; Lepley, D.; Dusek, R.; Cameron, T.; Pignata, S. |
| Abstract Title: | LIO-1: Initial phase 2 experience of lucitanib + nivolumab in patients with metastatic or recurrent cervical cancer (NCT04042116; ENGOT-GYN3/AGO/LIO) |
| Meeting Title: | 2022 Society of Gynecologic Oncology Annual Meeting |
| Journal Title: | Gynecologic Oncology |
| Volume: | 166 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Mar 18-21 |
| Meeting Location: | Phoenix, AZ |
| ISSN: | 0090-8258 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-08-01 |
| Start Page: | S24 |
| Language: | English |
| ACCESSION: | WOS:000892325300036 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0090-8258(22)01252-5 |
| Notes: | Meeting Abstract: 034 -- Source: Wos |
